A 46-year-old man was admitted to the Department of Gastroenterological Surgery, National Kyushu Cancer Center, because of gastric cancer of the cardia. A barium meal examination and upper gastrointestinal endoscopy disclosed a Borrmann type II tumor with esophageal invasion. Biopsy specimens from the tumor demonstrated moderately differentiated adenocarcinoma.
The patient underwent a total gastrectomy and lymph node dissection, with a combined resection of the spleen and the gallbladder. The resected specimen showed a tumor of the cardia, measuring 5 cm × 4 cm, which had macroscopically infi ltrated the entire thickness of the gastric wall, and which had invaded the abdominal esophagus to within 1 cm of the esophagogastric junction (Fig. 1A) . The tumor of the cardia was histologically revealed to be a moderately differentiated adenocarcinoma which had marked lymphatic permeation in the submucosal layer of the esophagogastric junction (Fig. 1B) . The proximal margin of the resected specimen was free of residual cancer cells and free of lymphatic invasion. Metastatic lymph nodes were found in some of the paracardial and the lesser curvature regions. The TNM stage of the tumor was pT3pN2M0.
Postoperatively, the patient received no adjuvant chemotherapy. However, 13 months after the operation, upper gastrointestinal endoscopy disclosed a fl atsurfaced, somewhat elevated tumor in the esophagus, 32 cm from the incisor teeth, which macroscopically resembled a 0-IIa-type primary esophageal cancer ( Fig.  2A) . This lesion measured 7 mm in diameter and was unstained with Lugol's solution (Fig. 2B) . The tumor was 5 cm proximal to the esophago-jejunal anastomosis, which was free of recurrent tumor. The biopsy specimens indicated a moderately to poorly differentiated adenocarcinoma. We fi rst suspected a primary esophageal cancer, along with the possibility of esophageal intramural metastasis from gastric cancer. Because
Introduction
Esophageal squamous cell carcinoma is often accompanied by intramural metastasis, which predicts a poor prognosis. The intramural metastasis of a gastric cancer to the esophageal wall, however, has rarely been reported. We herein report the case of a recurrent gastric adenocarcinoma with intramural metastases to the esophagus occurring 13 months after a total gastrectomy with lymph node dissection. esophageal endoscopic ultrasound (30 MHz) revealed that the extent of the tumor invasion was limited to the proper mucosal layer, the patient underwent a cap-assisted endoscopic mucosal resection (EMR). The tumor resected by the EMR demonstrated massive lymphatic permeation and displayed the same histological appearance as the previously resected gastric cancer (Fig. 2C) , therefore, we interpreted this esophageal tumor as an intramural metastasis from the gastric cancer, having spread via the lymphatic vessels in the esophageal wall. Two weeks after the EMR, several tiny fl at nodules, similar to the previous lesion, appeared 3 cm proximal to the EMR scar, and were shown to be moderately to poorly differentiated adenocarcinoma by histological examination. Because these new lesions were also thought to be intramural metastases from the gastric cancer, the administration of an oral fl uoropyrimidine, S-1 (100 mg/body), was started. However, similar fl at nodules of various sizes developed throughout the thoracic esophagus (Fig. 2D,E) . The patient developed multiple lymph node and bone metastases 23 months after the fi rst recurrence, and unfortunately died 27 months after the fi rst recurrence.
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Discussion
In Japan, squamous cell carcinoma is the most frequently identifi ed histological type of primary esophageal cancer, occurring in 92.0% of cases. Adenocarcinoma is found in only 1.6% of cases [1] . In esophageal squamous cell carcinoma, intramural metastases are reported to occur with an incidence ranging from 11.9% to 16.7% [2] [3] [4] , and are considered to be one of the most important prognostic factors [4] . An intramural metastasis of a gastric adenocarcinoma to the esophagus, however, has rarely been reported. The fi rst case of such a metastasis was reported in the English-language literature in 1998 [5] , and to our knowledge, only seven cases have since been reported, apart from the present case [5, 6] . Furthermore, only ten cases of such metastasis have been reported in the Japanese literature, even though Japan is a country with a very high incidence of gastric cancer [7] . Therefore, the occurrence of intramural metastasis of gastric cancer to the esophagus is thought to be a rare event.
Szántó et al. [6] documented the fi nding that intramural esophageal metastases were verifi ed in 6 (4.19%) of 143 patients with cardial adenocarcinoma in a retrospective study.
In all seven cases reported in the English-language literature [5, 6] , the intramural esophageal metastases were found synchronously along with the primary gastric cancer. Furthermore, six of the seven patients died within 1 year of diagnosis of the metastasis. However, the present patient had metachronous metastases and survived for 27 months after the fi rst recurrence, having been treated with S-1.
It was diffi cult for us to be certain as to the source of the metastases in our patient. However, both the abundant lymphatic network within the esophageal wall and the marked lymphatic invasion of the primary gastric cancer led us to believe that the gastric cancer cells had invaded the lymphatic vessels and spread into the esophageal wall. Hirota et al. [5] and Szántó et al. [6] noted that esophageal intramural metastases, both from gastric adenocarcinoma and from esophageal squamous cell carcinoma, had the same clinical impact; the intramural metastases from these cancers indicated systemic expansion of cancer through the intramural lymphatic system and heralded a poor prognosis [6] . In our patient, because it was possible that the solitary esophageal fl at elevation may have been a primary esophageal cancer, judging from its macroscopic appearance, we fi rst resected it by EMR. However, the histological examination strongly supported the possibility that this elevated lesion was an intramural metastasis from the gastric cancer. Moreover, immediately after the resection, new similar lesions emerged on the oral side of the esophagus. The EMR specimen showed a 0-IIa-type tumor located within the mucosal layer, with lymphatic invasion. This histological fi nding may indicate that an 0-IIa-type tumor is a primary esophageal adenocarcinoma. Nishimaki et al. [2] defi ned the morphological features of intramural metastases from esophageal carcinoma as the gross appearance of a submucosal tumor without any intraepithelial cancer extension. However, the following fi ndings strongly led us to believe that the tumor in our patient was indeed an intramural metastasis: (1) the fi nding of massive lymphatic invasion both in the previous gastric cancer and in the tumor resected by EMR; (2) the fi nding of the same histological type in both tumors; (3) the emergence of multiple esophageal lesions soon after the EMR resection; and (4) the very low incidence of esophageal adenocarcinoma in Japan.
We considered the state of the disease in our patient to be a systemic expansion of the gastric adenocarcinoma and we administered S-1 instead of performing a further EMR or an esophagectomy. The patient survived for longer than almost all other such patients who were treated with an esophagectomy [5, 6] . Some recent studies have reported the effectiveness of systemic chemotherapy, with agents such as S-1, for the treatment of recurrent gastric cancers [8, 9] . From the viewpoint of systemic disease, the administration of systemic chemotherapy, rather than performing an esophagectomy, may improve the prognosis of patients with esophageal intramural metastasis from gastric cancer.
In conclusion, the occurrence of esophageal intramural metastases from gastric cancer implies a systemic expansion of the gastric cancer, and portends a poor prognosis, in the same manner as that observed for intramural metastases from esophageal cancer. Determining the optimal treatment for such metastases requires the further accumulation of data regarding esophageal intramural metastases.
